Condition (MeSH)
Phyllodes Tumor
ClinicalTrials.gov lists 11 trials for Phyllodes Tumor or a narrower condition beneath it.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase
11 of the 11 trials are tagged with Phyllodes Tumor itself; the rest are tagged with a narrower condition beneath it.
When did Phyllodes Tumor trials start? (10)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Trials over time, by phase
- Phase 1
- Not applicable
- Observational
Top of scale: 1
Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.
| Year | Trials started |
|---|---|
| 2026 (partial year) | 2 |
| 2025 | 1 |
| 2024 | 1 |
| 2023 | 1 |
| 2021 | 1 |
| 2019 | 1 |
| 2018 | 1 |
| 2010 | 1 |
| 2005 | 1 |
| 1998 | 1 |
No forecast is made for this condition: it averages 1.0 trial starts a year over the five years to September, under the 5 a year the method needs.
Recruitment duration, a model prediction: none of the 11 trials evaluated at the 2026-10-09 snapshot is predicted and still running. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Phyllodes Tumor trials in? (3)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Phase 1 | 2 |
| Not applicable | 6 |
| Observational | 3 |
How many Phyllodes Tumor trials are recruiting? (7)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Not yet recruiting | 1 |
| Recruiting | 1 |
| Active, not recruiting | 1 |
| Completed | 5 |
| Terminated | 1 |
Showing 5 of 7 statuses.
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which lead sponsors run the most Phyllodes Tumor trials? (2)
Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.
| Sponsor | Trials |
|---|---|
| KK Women's and Children's Hospital | 1 |
| Valerio Therapeutics | 1 |
Which drugs are being tested for Phyllodes Tumor? (1)
Shown in this order: most trials first. One row per drug, matched to a single molecule under all its names, ranked by number of trials.
| Drug | Trials |
|---|---|
| Belinostat | 1 |
Interventions as named in the registry (2)
Shown in this order: most trials first.
| Drug | Trials |
|---|---|
| CRYOTHERAPY | 1 |
| Fluorouracile | 1 |
These are the names sponsors entered on ClinicalTrials.gov that we have not matched to a single molecule. Some are drugs under a brand or code name; others are procedures, doses or arm labels.
Which publications cover Phyllodes Tumor? (21)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| Phyllodes tumors of the breast: A comprehensive review of diagnosis, treatment, and follow-up. | Clinics (Sao Paulo, Brazil) | 2025 | Yes |
| Postoperative radiation therapy in localized breast malignant phyllodes tumors: RPA-derived risk model identifies high-benefit subgroups with local control improvement. | Breast (Edinburgh, Scotland) | 2025 | Yes |
| Phyllodes tumour evidence gaps mapped from the 5th edition of the WHO classification of tumours of the breast. | Histopathology | 2023 | Yes |
| Artificial intelligence modelling in differentiating core biopsies of fibroadenoma from phyllodes tumor. | Laboratory investigation; a journal of technical methods and pathology | 2022 | Yes |
| Management of phyllodes tumor: A systematic review and meta-analysis of real-world evidence. | International journal of surgery (London, England) | 2022 | Yes |
Showing 5 of 21 publications.
Rare-disease identity (2)
Shown in this order: exact, broader, narrower, other.
| Orphanet disease | ORPHA code | Relation | Source |
|---|---|---|---|
| Phyllodes tumor of the breast | 180261 | Exact | Orphanet Rare Disease Ontology (ORDO) |
| Phyllodes tumor of the breast | 180261 | Exact | Orphadata Science knowledge files, Product 1 |
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: serious adverse events in this condition's trials, prevalence, and sub-conditions in mesh.